All In Biotech

Drug Trial Radar · NCT02128633

Effectiveness of a Homecare Dentin Hypersensitivity Gel

EFFECTIVENESS OF A HOMECARE DESENSITIZER FOR PATIENTS WITH DENTIN HYPERSENSITIVITY

Last checked: Nov 19, 2026Latest source record: May 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 126 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

126

Actual

Start

Nov 2009

Primary completion

Jun 2013

Study completion Mar 2014

Sponsor

Lead sponsor
Universidade Federal de Santa MariaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Franciscan University Center
First posted
May 1, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Aim: To evaluate the effectiveness of a desensitizing gel for topical and home use in the treatment of dentin hypersensitivity (DH) through a randomized clinical trial, double-blind, with three parallel treatment. Methods: 126 subjects were divided into three groups: placebo gel (PG), test gel (TG) (5% sodium fluoride, potassium oxalate 5%, strontium chloride 10%) and sodium fluoride gel (2% FG ). The measurement of DH was performed by a single examiner blinded by the visual analog scale (VAS) after tactile, thermal and osmotic stimuli in the Baseline, 7, 15 and 30 days.

Conditions

  • Dentin Sensitivity

Interventions

  • placebo gelDrug

    Manipulated at Novaderme ®, Santa Maria, RS, Brazil.

  • 5% sodium fluoride, potassium oxalate 5%, strontium chloride 10%Drug

    Manipulated at Novaderme ®, Santa Maria, RS, Brazil.

  • Fluoride neutral NaF gel 2 %Drug

    The product had similar appearance and viscosity than others.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. dentine hypersensitivity with visual analog scale (VAS) following tactile, thermal and osmotic stimulusTime frame: Change from Baseline in VAS Scale at 7 days.
  2. dentine hypersensitivity with visual analog scale (VAS) following tactile, thermal and osmotic stimulusTime frame: Change from Baseline in VAS Scale at 15 days.
  3. dentine hypersensitivity with visual analog scale (VAS) following tactile, thermal and osmotic stimulusTime frame: Change from Baseline in VAS Scale at 30 days.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fabricio Batistin Zanatta

    Santa Maria, Rua Floriano Peixoto--, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.